Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dual Antiplatelet Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05063630
What this trial is testing

Intracranial Stenting in Non-acute Symptomatic Ischemic Stroke

Who this might be right for
Intracranial ArteriosclerosisIschemic StrokeIntracranial Arterial Diseases+1 more
Can Tho Stroke International Services Hospital 300
Not applicableWithdrawnNCT06857045
What this trial is testing

Comparison Three vs Six Months of Dual Anti-platelet Therapy After Sirolimus-eluting Stent Implantation

Who this might be right for
Intracranial ArteriosclerosisIntracranial Artery StenosisDrug-Eluting Stents
Sino Medical Sciences Technology Inc.
Early research (Phase 1)Study completedNCT03698513
What this trial is testing

Assess Administration of an Oral Anti-thrombotic With Antiplatelet Therapy in Healthy Subjects

Who this might be right for
Healthy Volunteers
Bristol-Myers Squibb 113
Post-approval studies (Phase 4)Study completedNCT07622056
What this trial is testing

Pharmacodynamic and Short-term Effects of Half-dose Ticagrelor With or Without Aspirin vs DAPT From Day of PCI in CCS

Who this might be right for
Coronary Heart Disease
Kaohsiung Veterans General Hospital. 54
Not applicableUnknownNCT03664388
What this trial is testing

Registry of Acute Coronary Syndrome From University Hospital of Vigo

Who this might be right for
Acute Coronary Syndrome
Hospital Álvaro Cunqueiro 8,000
Not applicableUnknownNCT03338335
What this trial is testing

Ethnic Differences and the Ischemia/Bleeding Risk of DAPT Duration

Who this might be right for
Coronary Artery DiseasePercutaneous Coronary InterventionDual Antiplatelet Therapy
Seoul National University Hospital 16,000
Post-approval studies (Phase 4)UnknownNCT03103685
What this trial is testing

Continue vs. Stop P2Y12 Inhibitor on Bleeding in Patient Receiving DAPT Undergoing Dental Procedure.

Who this might be right for
Dental DiseasesAntiplatelet AgentsAntiplatelet Drugs
Chiang Mai University 428
Post-approval studies (Phase 4)Study completedNCT01145079
What this trial is testing

A New Strategy Regarding Discontinuation of Dual Antiplatelet

Who this might be right for
Coronary Artery Disease
Yonsei University 982
Testing effectiveness (Phase 2)Study completedNCT03599284
What this trial is testing

The Efficacy, Safety and Pharmacokinetic of Antiplatelet Therapy for Vicagrel

Who this might be right for
Coronary Artery DiseasePercutaneous Coronary InterventionPlatelet Aggregation Inhibitors
Jiangsu vcare pharmaceutical technology co., LTD 279
Post-approval studies (Phase 4)Study completedNCT01659034
What this trial is testing

Short and Optimal Duration of Dual Antiplatelet Therapy Study

Who this might be right for
Coronary Artery Disease
Takeshi Morimoto 1,525
Post-approval studies (Phase 4)Study completedNCT01995370
What this trial is testing

Cilostazol Stroke Prevention Study for Antiplatelet Combination

Who this might be right for
Noncardioembolic Cerebral Infarction
Japan Cardiovascular Research Foundation 1,884
Not applicableUnknownNCT02837003
What this trial is testing

3-Month Discontinuation of Dual Antiplatelet Therapy After Ultimaster Sirolimus-Eluting Stent Implantation

Who this might be right for
Coronary Artery Disease
Teikyo University 1,500
Post-approval studies (Phase 4)Study completedNCT02567461
What this trial is testing

Edoxaban in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy With Aspirin and Clopidogrel

Who this might be right for
Coronary Artery Disease
University of Florida 80
Not applicableStudy completedNCT02051361
What this trial is testing

Antiplatelet Therapy Following Stent Implantation

Who this might be right for
Acute Myocardial InfarctionCoronary SyndromeAngina, Unstable
Elpen Pharmaceutical Co. Inc. 900
Large-scale testing (Phase 3)UnknownNCT00774475
What this trial is testing

Dual Antiplatelet Therapy Tailored on the Extent of Platelet Inhibition

Who this might be right for
Unstable AnginaNSTEMI
University of Florence 442
Not applicableUnknownNCT01233167
What this trial is testing

Effect of Different Anti-platelet Strategies on the Long-term Outcome After Sirolimus Drug-eluting Stent Implantation

Who this might be right for
Coronary Artery Disease
Sir Run Run Shaw Hospital 5,232
Post-approval studies (Phase 4)UnknownNCT03112707
What this trial is testing

Bioresorbable Polymer-Coated EES in Patients at High Bleeding Risk Undergoing PCI Followed by 1-Month DAPT

Who this might be right for
Coronary Artery DiseaseAcute Coronary Syndrome
Humanitas Hospital, Italy 1,023
Not applicableStudy completedNCT04289012
What this trial is testing

HELicobacter Pylori Screening in Patients With Acute Myocardial Infarction Pilot Study

Who this might be right for
STEMI - ST Elevation Myocardial InfarctionNSTEMI - Non-ST Segment Elevation MI
Karolinska Institutet 300
Large-scale testing (Phase 3)Looking for participantsNCT06653348
What this trial is testing

Ticagrelor Based De-Escalation of Dual Antiplatelet Therapy in Ischemic Stroke

Who this might be right for
Ischemic StrokeTransient Ischemic Attack
Mazandaran University of Medical Sciences 100
Post-approval studies (Phase 4)Study completedNCT03431142
What this trial is testing

Optimal antiPlatelet Therapy for High Bleeding and Ischemic RISK Patients Trial

Who this might be right for
Prolonged DAPT in ACS Patients With Hisk of Both Ischemic and Hemorrhage
Shenyang Northern Hospital 7,758
Next Page